Sara Ansaloni

Title: Innovations by Sara Ansaloni in Drug Delivery Systems

Introduction

Sara Ansaloni is a prominent inventor based in San Jose, California. She has made significant contributions to the field of drug delivery systems, particularly in the area of therapeutic agents for clotting disorders. With a total of four patents to her name, Ansaloni's work is paving the way for advancements in medical treatments.

Latest Patents

One of her latest patents focuses on clotting factor preparations for delivery into the tissue of the intestinal tract using a swallowable drug delivery device. This innovative approach provides devices, preparations, and methods for delivering therapeutic agents, such as clotting factors, within the gastrointestinal tract. The embodiments include a swallowable capsule designed to deliver therapeutic agents into the intestinal wall. These preparations are configured to be contained within the capsule and can be advanced into the intestinal wall or surrounding tissue, where they degrade to release the therapeutic agent into the bloodstream, producing a therapeutic effect. This invention is particularly beneficial for treating clotting disorders, such as hemophilia, where clotting factors are often poorly absorbed or degraded within the gastrointestinal tract.

Career Highlights

Sara Ansaloni is currently employed at Rani Therapeutics, LLC, where she continues to innovate in the field of drug delivery. Her work is characterized by a commitment to improving patient outcomes through advanced medical technologies.

Collaborations

Some of her notable coworkers include Mir A Imran and Radhika Korupolu, who contribute to the collaborative environment at Rani Therapeutics.

Conclusion

Sara Ansaloni's contributions to drug delivery systems exemplify the impact of innovative thinking in medicine. Her patents are set to enhance the treatment of clotting disorders, showcasing the importance of research and development in healthcare.